Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.84 +0.08 (+0.22%)
As of: Sep 9, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Operating Margin (QoQ) (2009 - 2026)

Analysis

Teva Pharmaceutical Industries (TEVA) Operating Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,195.00
Mar 31, 2026 1,001.00
Dec 31, 2025 -1,332.00
Sep 30, 2025 879.00
Jun 30, 2025 -244.00
Mar 31, 2025 1,434.00
Dec 31, 2024 18.00
Sep 30, 2024 -106.00
Jun 30, 2024 559.00
Mar 31, 2024 -2,267.00
Dec 31, 2023 803.00
Sep 30, 2023 2,580.00
Jun 30, 2023 -1,651.00
Mar 31, 2023 2,385.00
Dec 31, 2022 -3,600.00
Sep 30, 2022 3,734.00
Jun 30, 2022 -607.00
Mar 31, 2022 -2,138.00
Dec 31, 2021 -1,413.00
Sep 30, 2021 114.00